TOP 5 MOST VIEWED ARTICLES
RECENT COMMENTS
-
David Ryner (don't play with numbers): I agree with Duncan and thank you Kathy. I number myself amongst many who suffer from a cr [...] »Read more
-
Duncan Jefferson (don't play with numbers): A very common sense article and one that should be taken on board by all in the Health "In [...] »Read more
-
Ken Campbell (recording consultations): I am clinical information offider for a UK cancer charity. I often recommend to patients t [...] »Read more
-
Frank (recording consultations): Yes I had a pt request a consultation with me - I am concerned about the medicolegal aspec [...] »Read more
-
Nicola Nicolai, Lara Bellardita, Massimo Maffezzini, Tiziana Magnani, Riccardo Valdagni and the Prostate Cancer Program Multidisciplinary Team at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan: The topic is of great interest, with good points in favour as well as against the referral [...] »Read more
-
Marian marie: It was next to impossible to manage my Thyroid Cancer after I had a Thyroidectomy in 1976. [...] »Read more
-
Paul CORNES (centralising cancer services): Thank you both - I enjoyed reading this. The best systematic review on the topic comes [...] »Read more
-
Steven Vermeulen: I was diagnose with adenocarcinoma with unknown primary in Oct. 2009. I was 54 years old, [...] »Read more
-
Wolfgang Grisold (cancer treatment: agesim): Thank you for raising this interesting issue. Personally , I have the impression that at l [...] »Read more
-
Gloria Freilich (cancer treatment: ageism): In my experience, having worked in the field of breast cancer from l987 to 2008 in a Londo [...] »Read more
GrandRound
Issue 25
The hopes and frustrations of a career in cancer: the next generation speaks out
Issue 24
Translating good science into new treatments
Issue 23
Personalised cancer therapies: why we may never reach the promised land
Issue 22
No trials about us without us! Patient advocates demand a seat at the table
Our responsability, our choices: ESO invites the media to a reality check on cancer
Issue 21
Breast screening: it's a question of pros and cons, not right or wrong
Issue 20
It's creative chaos in the colorectal cancer clinic: report from the ESO colorectal cancer observatory
Issue 19
Bridging the communications gap: how to build a dialogue with shocked, scared and sad patients
Issue 18
When treatment gets under your skin
Issue 17
Don't sideline the guidelines
Issue 16
A second opinion, because there's no second chance
Issue 15
Turn up the volume
Issue 14
Targeted drug development by trial or error?
Issue 13
Are you feeling lucky? Discussing risk and treatment options with patients
Issue 12
The dream team: when will we make it a reality?
Issue 11
Beyond the Herceptin hype...we need to raise the level of debate -
Issue 10
What’s coming up in colorectal cancer?
Lost in translation
Issue 9
"We will help you live until you die" and What's coming up in breast cancer
Issue 8
On the road to a single European cancer society
Issue 7
European research crisis: the cancer community must make its voice heard
Issue 6
They could be alive today
Issue 5
Treating anaemia: damned if you do, damned if you don’t
Issue 4
Cancer in pregnancy: the cruellest dilemma
Issue 3
Locoregional techniques: under-rated and under-researched
A good prognosis for progress in breast cancer
Issue 2
It’s not a war…and we are not losing
Issue 1
Cancer in the year 2025
CancerWorld invites you to visit:
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.

